SCHEMBL22065337

SCHEMBL22065337

N#Cc1ccc(-c2c(-c3ccc4cc(-c5cccc6cccnc56)ccc4c3)ccc3ccccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP1 P07148 1/20 0.45
PIM1 P11309 2/20 0.41
SLC40A1 Q9NP59 1/20 0.40
GLO1 Q04760 1/20 0.39
CYP11B1 P15538 3/20 0.39
CYP11B2 P19099 3/20 0.39
CYP17A1 P05093 1/20 0.39
SLC22A12 Q96S37 1/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
EGLN1 Q9GZT9 1/20 0.37
HRH4 Q9H3N8 1/20 0.37
PDPK1 O15530 1/20 0.37
PARP1 P09874 1/20 0.37
BRD4 O60885 1/20 0.37
KDM4E B2RXH2 1/20 0.36
GMNN O75496 1/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22064664 0.97 FABP1 (0.44) FABP1PIM1SLC40A1GLO1CYP11B1
SCHEMBL22064687 0.91 FABP1 (0.51) FABP1PIM1SLC40A1GLO1CYP11B1
SCHEMBL22064808 0.89 CYP11B2 (0.40) FABP1PIM1SLC40A1GLO1CYP11B1
SCHEMBL22064807 0.87 FABP1 (0.41) FABP1PIM1SLC40A1GLO1CYP11B1
SCHEMBL22065457 0.87 FABP1 (0.42) FABP1PIM1SLC40A1GLO1CYP11B1
SCHEMBL22064686 0.86 FABP1 (0.39) FABP1PIM1SLC40A1GLO1CYP11B1
SCHEMBL22064669 0.86 FABP1 (0.53) FABP1SLC40A1GLO1CYP11B1CYP11B2
SCHEMBL22065185 0.85 FABP1 (0.49) FABP1SLC40A1GLO1CYP11B1CYP11B2
SCHEMBL22065335 0.85 FABP1 (0.47) FABP1PIM1SLC40A1GLO1CYP11B1
SCHEMBL22064670 0.84 FABP1 (0.47) FABP1PIM1SLC40A1GLO1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200181096-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181096-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, AHR FABP1 4043/4885PIM1 2372/4885SLC40A1 2383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.